Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSX/APS stock hub

TSX/APS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TSX/APSis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
6M
Toronto Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TSX/APS
In the news

Latest news · TSX/APS

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11P50 15.6P75 25.4
Trailing P/En/a
P25 7.4P50 15.6P75 34.3
ROEn/a
P25 -121.5P50 -40.9P75 0.5
ROIC-504.8
P25 -72.5P50 -16P75 1.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TSX/APS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
148
Groups with data
11
Currency
USD
Showing 148 of 148 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Canada
Country code
CA
Employees
14
Employees Change
1%
Employees Change Percent
7.69
Enterprise value
CAD 42M
Exchange
Toronto Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biotechnology
Isin
CA03835T2002
Last refreshed
2026-05-10
Market cap
CAD 6M
Price
CAD 2.35
Price currency
CAD
Sector
Healthcare
Sic
2836
Symbol
tsx/APS
Website
https://www.aptose.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-582.17%
EV Earnings
-1.2x
P/B ratio
-0.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

7
MetricValue
Net Income
CAD -34.9M
Net Income Growth Years
0%
Profit Per Employee
CAD -2.5M
ROA
-153.5
Roa5y
-95.35
ROCE
-3,501.8
ROIC
-504.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr10y
-47.45%
Cagr15y
-39.36%
Cagr1y
9.31%
Cagr20y
-39.62%
Cagr3y
-80.72%
Cagr5y
-75.47%
EPS Growth Years
0
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

15
MetricValue
Assets
CAD 13.7M
Cash
CAD 1.3M
Current Assets
CAD 8.8M
Current Liabilities
CAD 12.7M
Debt
CAD 37.3M
Equity
CAD -37.2M
Interest Coverage
-29.33
Liabilities
CAD 51M
Long Term Assets
CAD 4.9M
Long Term Liabilities
CAD 38.3M
Net Cash
CAD -36M
Net Cash By Market Cap
CAD -601
Tangible Book Value
CAD -37.2M
Tangible Book Value Per Share
CAD -14.59
WACC
2.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
0.69
Net Working Capital
CAD -4.9M
Quick ratio
0.1
Working Capital
CAD -3.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-250.13%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-99.84%
1Y total return
9.3%
200-day SMA
2.03
3Y total return
-99.28%
50-day SMA
2.26
50-day SMA vs 200-day SMA
50over200
5Y total return
-99.91%
All Time High
1,425,747.7
All Time High Change
-100%
All Time High Date
2000-03-06
All Time Low
1.02
All Time Low Change
130.39%
All Time Low Date
2025-06-18
ATR
0.07
Beta
0.29
Beta1y
0.29
Beta2y
-0.97
Ch YTD
10.85
High
2.35
High52
2.65
High52 Date
2025-05-08
High52ch
-11.32%
Low
2.35
Low52
1.02
Low52 Date
2025-06-18
Low52ch
130.39%
Ma50ch
3.94%
Price vs 200-day SMA
15.76%
RSI
52.93
RSI Monthly
31.84
RSI Weekly
48.57
Sharpe ratio
0.22x
Sortino ratio
0.38
Total Return
-250.13%
Tr YTD
10.85
Tr15y
-99.94%
Tr1w
-0.42%
Tr3m
5.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
CAD -33.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

9
MetricValue
Float
1,855,625%
Net Borrowing
25,358,777.5
Shares Insiders
7.37%
Shares Institutions
3.91%
Shares Out
2,552,429
Shares Qo Q
0.05%
Shares Yo Y
250.13%
Short Float
0.05%
Short Shares
0.04

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

43
MetricValue
Average Volume
3,646.45x
Bv Per Share
-14.59
Ch10y
-99.84
Ch15y
-99.94
Ch1w
-0.42
Ch1y
9.3
Ch20y
-100
Ch3m
5.38
Ch3y
-99.28
Ch5y
-99.91
Ch6m
25
Change
6.33%
Change From Open
0
Close
2.21
Days Gap
6.33
Depreciation Amortization
30,075.1
Dollar Volume
4,044.4
Earnings Date
2026-04-02
EBIT
CAD -33.9M
EBITDA
CAD -33.9M
EPS
CAD -14.27
F Score
1
Financing CF
26,570,934
Fiscal Year End
December
Founded
1,986
Is Primary Listing
1
Last Earnings Date
2025-11-13
Last Report Date
2025-12-31
Last Split Date
2025-02-26
Last Split Type
Reverse
Ma150
2.1
Ma150ch
12.01%
Ma20
2.34
Ma20ch
0.64%
Net CF
-3,579,994
Open
2.35
Ppne
244,702
Price Date
2026-05-08
Relative Volume
0.48x
Share Based Comp
654,024
Tr20y
-100%
Tr6m
25%
Volume
1,721
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TSX/APS pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/APS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+9.3%
S&P 500 1Y: n/a
3Y total return
-99.3%
S&P 500 3Y: n/a
5Y total return
-99.9%
S&P 500 5Y: n/a
10Y total return
-99.8%
S&P 500 10Y: n/a
Ownership

Who owns TSX/APS?

Insider, institutional, and short-interest positioning.

Institutional ownership
+3.9%
Share of float held by funds and institutions
Insider ownership
+7.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+0.0%
Float sold short by bearish positioning
Y/Y dilution
+250.1%
Negative means the company is buying back shares.
Technical

TSX/APS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
52.9
Neutral momentum band
Price vs 200-day MA
+15.8%
50/200-day relationship not available
Beta (5Y)
0.29
Less volatile than the market
Sharpe ratio
0.22
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TSX/APS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/APS stock rating?

tsx/APS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/APS analysis?

The full report lives at /stocks/tsx/APS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/APS?

The latest report frames tsx/APS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/APS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.